GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Core One Labs Inc (XCNQ:COOL) » Definitions » Debt-to-Equity

Core One Labs (XCNQ:COOL) Debt-to-Equity : 0.04 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Core One Labs Debt-to-Equity?

Core One Labs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.25 Mil. Core One Labs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Core One Labs's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$5.64 Mil. Core One Labs's debt to equity for the quarter that ended in Dec. 2023 was 0.04.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Core One Labs's Debt-to-Equity or its related term are showing as below:

XCNQ:COOL' s Debt-to-Equity Range Over the Past 10 Years
Min: -10.4   Med: 0.05   Max: 5.58
Current: 0.04

During the past 11 years, the highest Debt-to-Equity Ratio of Core One Labs was 5.58. The lowest was -10.40. And the median was 0.05.

XCNQ:COOL's Debt-to-Equity is ranked better than
76.38% of 1071 companies
in the Biotechnology industry
Industry Median: 0.15 vs XCNQ:COOL: 0.04

Core One Labs Debt-to-Equity Historical Data

The historical data trend for Core One Labs's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Core One Labs Debt-to-Equity Chart

Core One Labs Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.04 0.60 0.08 0.01

Core One Labs Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.05 N/A 0.05 0.04

Competitive Comparison of Core One Labs's Debt-to-Equity

For the Biotechnology subindustry, Core One Labs's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core One Labs's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Core One Labs's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Core One Labs's Debt-to-Equity falls into.



Core One Labs Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Core One Labs's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Core One Labs's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Core One Labs  (XCNQ:COOL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Core One Labs Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Core One Labs's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Core One Labs (XCNQ:COOL) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 800, Vancouver, BC, CAN, V6E 3T5
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada's licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.